Skip to Content

322M 12.5/500 (Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 500 mg)

Pill with imprint 322M 12.5/500 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 500 mg. It is supplied by Perrigo New York Inc..

Alogliptin/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Alogliptin/metformin 12.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 322M 12.5/500

Alogliptin Benzoate and Metformin Hydrochloride

322M 12.5/500
12.5 mg / 500 mg
Elliptical / Oval
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Perrigo New York Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.